| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Psychology and Neuroscience and Behavior Program, University of Massachusetts, Amherst, Massachusetts 01003; and Department of Psychology and Center for Neuroscience Research, University at Albany-State University of New York, Albany, New York 12222
Address all correspondence and requests for reprints to: Princy S. Quadros, Department of Psychology, Tobin Hall, 135 Hicks Way, University of Massachusetts, Amherst, Massachusetts 01003. E-mail: pquadros{at}nsm.umass.edu.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A profound example of steroid receptor regulation of gene expression is the induction of progesterone receptor (PR) expression by estradiol, acting primarily through estrogen receptor (ER)-
(1, 2, 3). In the adult rodent brain, PR is highly regulated by estradiol within the medial preoptic nucleus (MPN) and the ventromedial nucleus of the hypothalamus (VMN) (4, 5, 6, 7, 8). For example, in the adult female rat, PR expression within the VMN is highly dependent on circulating estradiol levels, such that PR expression varies dramatically over the course of the estrous cycle (9) with the natural rise and fall of estradiol secretion from the ovary. Estradiol increases the levels of PR mRNA (8, 10, 11) and PR protein (12, 13, 14) in both regions. This is consistent with the evidence that the promoter region of the rat PR gene contains at least four consensus sequences for weak and imperfect, but functional, estrogen response elements (15).
Within the MPN of the developing brain, PR expression is highly regulated by estradiol in both males and females. Castration of males on the day of birth (16) or treatment of fetal males with the aromatase inhibitor, ATD (1,4,6-androstatrien-3-17-dione) (17), abolishes PR expression in the MPN, indicating that estradiol metabolized from testicular testosterone, can induce PR expression in the male MPN. Although PR expression can be induced in the perinatal female MPN by exogenous estrogen treatment (17), the ovary is steroidogenically quiescent until the second postnatal week (18, 19, 20, 21). Therefore, PR is virtually absent in the neonatal female MPN (16, 22, 23). The differential secretion of steroids in developing males and females results in a dramatic sex difference in PR expression within the MPN (24). However, by postnatal day (P) 14, after the initiation of estradiol secretion by the ovary, PR expression is increased in the female MPN (16) and the sex difference is attenuated.
If PR expression were regulated by estradiol in the neonatal VMN, as it is in the adult VMN and perinatal MPN, one would predict that the male VMN would express higher levels of PR than the female VMN. Experiment 1 examined PR expression in neonatal males and females. In contrast to the MPN, the results demonstrated that the levels of PR expression are higher in females than males, suggesting that sex differences in PR expression in the neonatal VMN may be independent of gonadal hormones. Therefore, experiment 2 assessed the effects of neonatal gonadectomy on PR expression in the VMN. Results suggested that the sex difference in PR expression is independent of gonadal hormones during early development. Additionally, PR expression in the neonatal female VMN is not regulated by ovarian hormones as it is in the adult. Therefore, experiment 3 examined the ability of estradiol to induce PR expression in the female VMN over the life span. Results from the present study indicate the regulation of PR expression by estradiol is sexually dimorphic, anatomically specific, and developmentally dependent.
| Materials and Methods |
|---|
|
|
|---|
Ovariectomy
Neonatal females (P1 or P7) were anesthetized by placing them on ice. With the aid of a dissecting microscope, bilateral incisions were made through the skin and muscle wall in the flank region. Both ovaries were removed with forceps. The muscle wall, as well as the skin, was sutured with silk and the wound sealed with Nexaband (Closure Medical Corp., Raleigh, NC). Pups were allowed to recover on a warming pad before being returned to their mothers. Sham ovariectomies were performed similarly but the ovaries were left intact.
Older animals (>P7) were anesthetized with 90 mg/kg ketamine (ip, Ketaset; Henry Schein, Inc., Melville, NY) and 20 mg/kg xylazine (im, Anased; Henry Schein). Bilateral incisions were made through the skin and muscle wall in the flank region. Both ovaries were ligated and removed. The muscle wall was sutured with silk and the skin was stapled shut. Sham ovariectomies were performed similarly, but the ovaries were left intact. Subjects were allowed to recover on a warming pad before being returned to their home cages.
Castration
P1 males were anesthetized by placing them on ice. With the aid of a dissection microscope, an incision, above the phallus and at the midline, was made through the skin and muscle wall. Both testes were removed with forceps. The muscle wall was sutured with silk and the skin was sealed with Nexaband. Pups were allowed to recover on a warming pad before being returned to their mothers. Sham castrations were performed similarly but the testes were left intact.
Experiment 1: PR expression in the MPN and VMN of postnatal male and females
PR expression is sexually dimorphic in the neonatal MPN, with males expressing higher levels of PR than females (24). To determine whether a similar sex difference in PR exists in the neonatal VMN, brains of males and females were collected as follows. On P7 and P14, female and male rats were anesthetized with a lethal dose of chloral-hydrate pentobarbital (0.25 M chloral hydrate, 0.08 M magnesium sulfate, 45 mM pentobarbital, 3 M ethyl alcohol, 4.5 M propylene glycol in distilled water, ip) and were intracardially perfused with 0.9% saline followed 5% acrolein in 0.1 M phosphate buffer [PB (pH 7.6)]. Brains were removed from the skull and postfixed in 5% acrolein in 0.1 M PB followed by cryoprotection in 30% sucrose in 0.1 M PB until time of sectioning. Brains were sectioned at 50-µm-thick sections in the coronal plane on a rotary microtome. Sections were stored in cryoprotectant (30% sucrose, 0.1% polyvinyl-pyrrolidone-40 in ethylene glycol and 0.1 M PB) at –20 C until processing for immunocytochemistry as described below.
Experiment 2: the effect of gonadectomy on PR expression in the MPN and VMN males and females
To assess the contribution of gonadal hormones to PR expression within the neonatal MPN and VMN of both sexes, male and female pups were gonadectomized on the day of birth, and PR expression was examined either before (P4) or after (P14) the onset of ovarian steroidogenesis. Within 18 h after birth, female and male pups were either gonadectomized (GDX) or sham GDX as described above. Brains from sham GDX and GDX animals were collected on P4 or P14 as follows. On P4, animals were anesthetized by hypothermia, and after rapid decapitation, brains were removed from the skull and immediately immersion-fixed in 5% acrolein in 0.1 M PB for 6 h and then cryoprotected in 30% sucrose in 0.1 M PB until the time of sectioning. On P14, animals were killed with a lethal dose of Nembutal (50 mg/kg, ip; pentobarbital sodium; Henry Schein). Animals were intracardially perfused with 0.9% saline followed by 5% acrolein in 0.1 M PB. Brains were removed from the skull and postfixed in 5% acrolein in 0.1 M PB followed by cryoprotection in 30% sucrose until time of sectioning. All brains were sectioned at 50 µm thickness in the coronal plane on a rotary microtome and stored in cryoprotectant at –20 C until immunocytochemical processing. P4 and P14 tissues were run in separate immunocytochemical trials and were therefore analyzed separately.
Experiment 3: estradiol induction of PR in the MPN and VMN of females across development
PR expression in the adult female VMN is highly dependent on estradiol. In contrast, PR expression in the neonatal female VMN does not appear to be dependent on ovarian hormones. To determine when during development PR expression becomes estradiol dependent in the VMN, female rats were challenged with a dose of estradiol benzoate (EB) at different ages, and PR expression was examined. On P1, female pups were randomly assigned to one of five age groups: P7, P14, P35, P49, and P67. Seven days before the animals were killed (i.e. on P1, P7, P28, P42, and P60) females were ovariectomized as described above. Two days before the animals were killed, half of the females in each age group were weighed and administered a single injection of EB (20 µg/kg in sesame oil, sc), whereas the other half received an equal volume of sesame oil alone.
On the day the animals were killed, animals were administered a lethal dose of Nembutal (50 mg/kg, ip; pentobarbital sodium; Henry Schein) followed by rapid decapitation. Brains were removed from the skull. Under a dissecting microscope, brains were sectioned at the midsagittal plane with a scalpel. Half of the brain was immediately immersed overnight in 5% acrolein in 0.1 M PB (pH 7.6), whereas the other half was frozen on powdered dry ice and stored at –80 C for use in another experiment. The acrolein-fixed half of each brain was cryoprotected in 30% sucrose in 0.1 M PB (pH 7.6). Brains were sectioned in the coronal plane on a rotary microtome at a thickness of 50 µm and stored in cryoprotectant at –20 C until immunocytochemical processing.
In addition, uterine horns from each animal were collected as a bioassay for EB treatment. Excess fat was removed and the uterine horns were weighed to the nearest 0.01 g.
Immunocytochemistry
Free-floating brain sections from each experiment were processed for immunocytochemistry in separate trials using a rabbit polyclonal antibody (Dako Inc., Glostrup, Denmark) directed against a region adjacent to the DNA binding domain of the human PR. This antibody detects both the A and B isoforms of PR (25). Details of this immunocytochemical process have been previously described in detail (17, 24). Briefly, brain sections were incubated in 1% sodium borohydride in Tris-buffered saline followed by incubation in blocking serum containing 20% normal goat serum, 1% H2O2, and 1% BSA. PR antiserum was diluted to 1:1000 and incubated with brain sections for 72 h. Sections were then incubated in biotinylated goat antirabbit IgG (Vector Laboratories, Burlingame, CA) at a concentration of 2.5–5 µg/ml. Next, sections were incubated in the ABC reagent (Vectastain Elite kit, Vector Laboratories) followed by incubation in a solution containing 0.05% diaminobenzidine, 0.75 mM nickel ammonium sulfate, 0.15% -β-D-glucose, 0.04% ammonium chloride, and 0.001% glucose oxidase. Sections were then rinsed in Tris-buffered saline, mounted onto gelatin-coated slides and allowed to air dry. Sections were then dehydrated, delipidated, and coverslipped with Permount (Fisher Scientific, Hampton, NH).
Analysis
A single representative section through the caudal aspect of the MPN and VMN ventrolateral division for each rat was selected for image analysis. Each section of the MPN and VMN was anatomically matched across rats using distinguishing landmarks (26, 27). Rats that did not contain an anatomical match for a region were excluded from the analysis of that region. Microscopic images of the PR immunoreactivity (PRir) in the MPN and VMN were captured with an Olympus BH-2 microscope fitted with a CCD72 camera (Dage MTI, Michigan City, MI) that was connected to a QuickCapture frame grabber board (Data Translation Inc., Marlboro, MA) in a MacIntosh IIfx computer. NIH Image software (hhtp://rsb.info.nih.gov/nih-image) was used to analyze captured image. The relative amount of PRir in the MPN and VMN was determined by measuring the area (square micrometers) covered by thresholded pixels [i.e. those pixels with a gray level higher than a defined threshold density (specific immunoreactive staining)]. Threshold was determined as a constant function of the background OD defined as the mean OD 3–5 times the SD higher than the mean background density. The mean background density was measured in a region devoid of PRir, immediately lateral to the analyzed region containing PRir.
Statistical analyses
In all experiments, relative total amount of PRir was analyzed using a two-way ANOVA followed by preplanned multiple post hoc comparisons using Student-Neuman-Keuls post hoc test (P < 0.05). In experiment 1, separate two-way ANOVAs (sex x age) was performed for the MPN and VMN. In experiment 2, separate two-way ANOVAs (GDX x sex) were performed for each region at P4 and P14. In experiment 3, separate two-way ANOVAs (EB treatment x age) were performed for the MPN and VMN. The effect of EB on uterine weights, in experiment 3, was assessed by a Students t test at each age. Uterine weights were not compared across ages because weights increased dramatically simply due to somatic growth.
| Results |
|---|
|
|
|---|
VMN.
Two-way ANOVA (age x sex) revealed significant main effects of age [F(1,21) = 4.9, P < 0.05] and sex [F (1, 21) = 18.9, P < 0.001]. There was no significant interaction between sex and age. Post hoc analysis revealed that females had significantly higher levels of PRir in the VMN, compared with males at both P7 (P < 0.05) and P14 (P < 0.01). There was no significant effect of age in either sex (Fig. 1
).
|
|
P4
VMN.
Two-way ANOVA (sex x gonadectomy) revealed that there was a significant main effect of sex [F(1,38) = 38.5, P < 0.001] and gonadectomy [F (1, 38) = 48.6, P < 0.001] and a significant interaction between sex and gonadectomy [F (1, 38) = 33.4, P < 0.001]. Post hoc analysis revealed that gonadectomy on the day of birth significantly reduced PRir in the VMN of P4 males (P < 0.001) but had no effect in females. PRir levels in the VMN did not differ between intact males and females, but gonadectomized females had significantly higher levels of PRir in the VMN, compared with GDX males (P < 0.05) (Figs. 3
and 4A
).
|
|
P14
VMN.
There was a significant main effect of sex [F(1,41) = 153.1, P < 0.001] but not gonadectomy. There was a significant interaction between sex and gonadectomy [F(1,41) = 8.5 (P < 0.01]. Post hoc analysis revealed that gonadectomy on the day of birth significantly reduced PRir in the VMN of females (P < 0.005) but had no effect in males. Intact females had significantly higher levels of PRir in the VMN than intact males (P < 0.001), and this sex difference persisted, even after gonadectomy (P < 0.001) (Figs. 5
and 6A
).
|
|
Experiment 3: estradiol induction of PR in the VMN and MPN of females across development
The effect of estradiol on PRir levels was dependent on age and region. Estradiol induced PRir in the MPN at P7 but did not alter PRir in the VMN of the same animals. However, estradiol increased PRir at all other ages in both regions.
VMN.
Estradiol significantly induced PRir in the VMN at all ages, except P7. Two-way ANOVA (EB treatment x age) revealed a significant main effect of age [F(4, 92) = 113.9, P < 0.001] and EB treatment [F (1, 92) = 630.479, P < 0.001] as well as a significant interaction between age and EB treatment [(F (4, 92) = 63.8, P < 0.001]. Post hoc analyses revealed that EB treatment significantly increased PRir in the VMN at P14, P35, P49, and P67 (P < 0.001). There was no significant effect of EB treatment at P7 (P = 0.163). Within oil-treated females, there was a significant increase in PRir levels between P7 and P14 (P < 0.001) and between P49 and P67 (P < 0.05). There was a significant decrease in PRir between P14 and P35 (P < 0.005) and no significant difference between P35 and P49. Within EB-treated females, PRir levels in the VMN were significantly higher at each age, compared with the previous age (P < 0.05) except at P49 (Fig. 7
).
|
|
|
| Discussion |
|---|
|
|
|---|
Sex differences in PR
In the MPN, males expressed higher levels of PRir, compared with females, consistent with previous reports from our laboratory (16, 24). This sex difference in the MPN is completely dependent on estradiol, resulting from the aromatization of testicular testosterone (17, 24). In the adult female VMN, PR expression is also highly dependent on circulating estradiol levels (10, 11). Therefore, it would be predicted that PR expression in the neonatal VMN would demonstrate a similar sex difference to that seen in the MPN. In stark contrast, however, PR expression was significantly higher in females, compared with males, at both P7 and P14. Moreover, PR expression in the P7 female VMN is relatively high, particularly in comparison with the virtual absence of PR expression in the MPN of the same females. Thus, the regulation of PR expression by estradiol in the neonatal female appears to be anatomically specific (i.e. highly dependent on estradiol in the MPN but seemingly independent of estradiol in the VMN). This suggests the existence of a mechanism that contributes to region-specific regulation of the PR gene.
Sex differences in the regulation of PR by gonadal hormones
The observed sex difference in PR levels in the VMN suggests that PR gene expression is regulated differentially in males and females. In males, the testes begin to secrete testosterone during gestation (19, 28, 29), whereas ovarian steroidogenesis does not occur until late in the second postnatal week (18, 19, 20, 30). In the present study, castration on the day of birth virtually abolished PR expression in the MPN and VMN of P4 males, suggesting that PR expression in these two regions in the neonatal male VMN is highly estradiol dependent (present findings and Ref. 16). Interestingly, when examined at P14, PR in the MPN abolished in castrated males, but there was no significant effect of castration on PR in the male VMN. In females, at P4, before the onset of ovarian estradiol secretion, there was no significant effect of neonatal ovariectomy on PRir in either the MPN or VMN. At P14, after the onset of ovarian steroidogenesis, PRir was only slightly reduced by neonatal ovariectomy in the VMN of females. In contrast, PRir was virtually abolished in the MPN of the same animals (present findings and Ref. 16). These findings demonstrate an interaction between age and sex in the estradiol-dependent regulation of PR expression in the VMN. Furthermore, these results are consistent with the idea that within the VMN, nongonadal factor(s) may be responsible for PR expression in males (at P14) and females (at P4).
The identity of such nongonadal factors is presently unknown. However, it is possible that PR expression in the developing female VMN is independent of estradiol but still dependent on ER
activation. Previous reports clearly demonstrate that ER
, rather than ERβ, is responsible for the induction of PR gene transcription (31, 32) and increasing PR protein in the brain (3, 33). Numerous in vitro studies now suggest that ER
can regulate gene expression in a ligand-independent manner (35, 36). For example, within MCF-7 as well as HeLa cell lines, ER
can be activated in the absence of ligand, recruit necessary transcription complexes and activate gene expression (35). The activation of ER
is dependent on its phosphorylation state. Under steroid-dependent conditions, ligand binding to the receptor results in phosphorylation. In the absence of ligand, cross talk with other intracellular signaling pathways may result in receptor phosphorylation. In the case of ER
, evidence indicates the involvement of growth factor receptor signaling pathways, in particular epidermal growth factor (37) and IGF-I (38). Whereas activation of ER
within the brain by growth factors has yet to be demonstrated, Olesen et al. (39) demonstrated the potential for ER activation via ligand-independent dopamine signaling pathways.
Regulation of PR by estradiol across development
The induction of PR expression by estradiol in the adult female VMN is well documented and represents one of the most robust examples of steroid-induced gene expression. In the adult female VMN, estradiol treatment of ovariectomized females increases PR binding (4, 5, 6), protein levels (12, 13, 14), and PR mRNA (8, 10, 11). In the present study, exogenous EB treatment significantly induced PR expression in the MPN at P7 but failed to alter PR levels in the VMN of the same animals. This is in stark contrast to the VMN at all other ages examined, in which EB treatment significantly increased PR beginning on, at least, P14. Furthermore, the dose of EB used in the present study was physiologically active because it significantly increased uterine weights in females of all ages, including P7. Therefore, these results reveal a developmental switch within the VMN that becomes engaged sometime between P7 and P14 and permits estradiol to induce the PR gene. The underlying factor(s) and molecular mechanisms involving changes in responsiveness to estradiol presently remain unexplored.
The inability of estradiol to induce PR in the neonatal rat VMN is a phenomenon that appears to be species specific. Estradiol-mediated regulation of PR expression in brain is a highly conserved phenomenon present in whiptail lizards (40, 41), sheep (42), cows (43), and chickens (44) as well as frogs (45) among other species. Even within the neonatal mouse, PRir is highly dependent on estradiol and ER
(2), elucidating interesting and important species differences between rats and mice (46), even in what is considered to be a relatively robust endocrine phenomenon. In this light, the neonatal VMN of the female rat may be a unique and powerful model in which to study the mechanisms underlying the specificity of steroid-induced gene transcription.
The mechanisms that permit this specificity are not well understood. Differential expression of ER
cannot account for this specificity because ER
is expressed at high levels in both the neonatal MPN and VMN (47, 48). However, factors that influence local estradiol levels or activity of ER
are possible. For example, it has long been accepted that the developing female brain was protected from estradiol exposure by high levels of the estrogen-binding protein
-fetoprotein (49, 50, 51, 52, 53 but see also Refs. 54 and 55), which is at high levels in circulation during perinatal life but declines over the second and third weeks after birth (56). However, circulating
-fetoprotein cannot explain the region-specific sensitivity to estradiol in the present study in which EB treatment increased PR expression almost 120-fold over controls in the MPN at P7 but less than 1.5-fold in the VMN of the same animals. The presence of
-fetoprotein within neurons (57, 58), though, suggests that estradiol may be bound, and perhaps sequestered, by
-fetoprotein within individual cells of the brain and may do so in an anatomically specific manner.
Another possibility is that a factor or factors may be inhibiting ER
in the neonatal female VMN, preventing estradiol binding and/or ER
transcriptional activity. Indeed, in vitro studies demonstrate that the LIM (Lin-11, Isl-1, and Mec 3)/homeodomain protein, Islet-1, can interfere with the formation of ER
homodimers, thus preventing DNA binding and transcription of estrogen sensitive genes (59). Interestingly, preliminary evidence from our laboratory demonstrates that levels of Islet-1 expression are consistent with an inhibitory role of this protein in ER
activity, suggesting that factors such as Islet-1 may regulate anatomical and developmental specificity, as well as sex differences in steroid-induced gene expression.
Conclusions
PR appears to be uniquely regulated in the VMN of neonatal female rats and appears to be disengaged from estradiol regulation. Unlike most other regions of the hypothalamus, PR expression in the developing VMN is not predictably regulated by estradiol. Factors such as sex, age, and region appear to illuminate the conditions under which PR may be regulated by estradiol. This may represent a critical factor in the normal development of the female VMN because estradiol is known to exert masculinizing effects on the developing rat brain (for review see Ref. 60), and the VMN is critically involved in female reproductive behavior in adulthood (for review see Refs. 34 and 61). Furthermore, the present findings reveal the VMN as a unique and important in vivo model in which to examine the factors that regulate the specificity underlying steroid-induced gene transcription.
| Acknowledgments |
|---|
| Footnotes |
|---|
Current address for C.K.W.: Department of Psychology, Center for Neuroscience Research, Social Science 369, University at Albany, Albany, New York 12222. E-mail: cwagner{at}albany.edu.
Disclosure statement: P.S.Q. and C.K.W. have nothing to declare.
First Published Online February 28, 2008
Abbreviations: EB, Estradiol benzoate; ER, estrogen receptor; GDX, gonadectomized; MPN, medial preoptic nucleus; P, postnatal day; PB, phosphate buffer; PR, progesterone receptor; PRir, PR immunoreactivity; VMN, ventromedial nucleus.
Received August 14, 2007.
Accepted for publication February 19, 2008.
| References |
|---|
|
|
|---|
gene-disrupted mice. J Neurosci 15:9556–9563
expression. J Neurobiol 47:176–182[CrossRef][Medline]
and β knockout mice reveal differences in neural oestrogen-mediated progestin receptor induction and female sexual behaviour. J Neuroendocrinol 15:978–983[CrossRef][Medline]
mRNA and progesterone receptor mRNA in the female rate hypothalamus during aging: an in situ hybridization study. Neurosci Res 38:85–92[CrossRef][Medline]
-hydroxylase/C17–20 lyase, and P450 aromatase in fetal mouse gonads. Endocrinology 135:262–268[Abstract]
-specific, estradiol-dependent expression of the progesterone receptor (PR)-B isoform. J Steroid Biochem Mol Biol 88:131–142[CrossRef][Medline]
-disrupted mice. Proc Natl Acad Sci USA 94:11008–11012
: regulation by phosphorylation sites in the AB region depends on other receptor domains. Mol Endocrinol 17:1296–1314
concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen. FASEB J 18:81–93
by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells. Mol Carcinog 45:551–560[CrossRef][Medline]
, and the type II glucocorticoid receptor are expressed in the same neurons of the ovine preoptic area and arcuate nucleus: a triple immunolabeling study. Biol Reprod 67:1605–1612
-immunoreactivity in the preoptic brain, the diencephalons, and the amygdala in the rat. J Comp Neurol 389:81–93.[CrossRef][Medline]
foetoprotein. Nature 263:685–687[CrossRef][Medline]
-Fetoprotein protexts the developing female mouse brain from masculinization and defeminization by estrogens. Nat Neurosci 9:220–226[CrossRef][Medline]
-fetoprotein, albumin and transferrin immunoreactivity in neurones of the developing mouse brain. Nature 286:733–735[CrossRef][Medline]
-fetoprotein in developing mouse brain. Brain Res 281:213–217[Medline]This article has been cited by other articles:
![]() |
D. M. Walker, T. E. Juenger, and A. C. Gore Developmental Profiles of Neuroendocrine Gene Expression in the Preoptic Area of Male Rats Endocrinology, May 1, 2009; 150(5): 2308 - 2316. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Gonzales, M. J. Tetel, and C. K. Wagner Estrogen Receptor (ER) {beta} Modulates ER{alpha} Responses to Estrogens in the Developing Rat Ventromedial Nucleus of the Hypothalamus Endocrinology, September 1, 2008; 149(9): 4615 - 4621. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |